AI Terminal
Marinomed Biotech AG
Declaration of Voting Results & Voting Rights Announcements • Jun 4, 2025
749_rns_2025-06-04_64a1cfde-c646-4cb4-989f-7833ce8a472d.html
Declaration of Voting Results & Voting Rights Announcements
Open in ViewerOpens in native device viewer
News Details
Voting rights Announcements | 4 June 2025 09:30
Marinomed Biotech AG: Release according to Article 135, Section 2 BörseG with the objective of Europe-wide distribution
Marinomed Biotech AG
Marinomed Biotech AG: Release according to Article 135, Section 2 BörseG with the objective of Europe-wide distribution
04.06.2025 / 09:30 CET/CEST
Dissemination of a Voting Rights Announcement transmitted by EQS News – a service of EQS Group.
The issuer is solely responsible for the content of this announcement.
Major holdings notification pursuant to Sec. 130 to 134 BörseG 2018
Wien, 3.6.2025
Overview
☒ Notification made after deadline
Caution: In case of violations of major holdings notification rules, please pay attention to Section 137 BörseG 2018 (Suspension of voting rights)
1. Issuer: Marinomed Biotech AG
2. Reason for the notification: Acquisition or disposal of voting rights
3. Person subject to notification obligation
Abdulmohsen Al Sheikh
4. Name of shareholder(s):
5. Date on which the threshold was crossed or reached: 20.1.2025
6. Total positions
| % of voting rights attached to shares (7.A) | % of voting rights through financial/other instruments (7.B.1 + 7.B.2) | Total of both in % (7.A + 7.B) | Total number of voting rights of issuer | |
| Resulting situation on the date on which threshold was crossed / reached | 3,94 % | 0,00 % | 3,94 % | 1 778 333 |
| Position of previous notification (if applicable) | 4,60 % | 0,00 % | 4,60 % |
Details
7. Notified details of the resulting situation:
| A: Voting rights attached to shares | ||||
| ISIN Code | Number of voting rights | % of voting rights | ||
| Direct (Sec 130 BörseG 2018) |
Indirect (Sec 133 BörseG 2018) |
Direct (Sec 130 BörseG 2018) |
Indirect (Sec 133 BörseG 2018) |
|
| ATMARINOMED6 | 70 115 | 3,94 % | ||
| SUBTOTAL A | 70 115 | 3,94 % |
| B 1: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 1 BörseG 2018 | ||||
| Type of instrument | Expiration Date | Exercise Period | Number of voting rights that may be acquired if the instrument is exercised |
% of voting rights |
| SUBTOTAL B.1 |
| B 2: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 2 BörseG 2018 | |||||
| Type of instrument | Expiration Date | Exercise Period | Physical / Cash Settlement |
Number of voting rights |
% of voting rights |
| SUBTOTAL B.2 |
8. Information in relation to the person subject to the notification obligation:
☒ Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.
☐ Full chain of controlled undertakings through which the voting rights and/or the financial/other instruments are effectively held starting with the ultimate controlling natural person or legal entity:
9. In case of proxy voting
Date of general meeting: –
Voting rights after general meeting: – is equivalent to – voting rights.
10. Sonstige Kommentare:
–
Wien am 3.6.2025
04.06.2025 CET/CEST
| Language: | English |
| Company: | Marinomed Biotech AG |
| Hovengasse 25 | |
| 2100 Korneuburg | |
| Austria | |
| Internet: | www.marinomed.com |
| End of News | EQS News Service |
2150548 04.06.2025 CET/CEST